Avid Bioservices Inc (CDMO)

[volgoat]

My brother in law was at Immunex for 10 years and now at Amgen ever since the buyout years back....He has told me repeatedly, there is NO WAY to go alone once PHIII's start....Too much money, too much man power needed, and too much experience needed...A small biotech does not have any of the above...The key is to find the best partner and best deal to move the drug forward in a timely manner.
He told me last week that the main focus for Amgen is to do deals and that goes for the entire BP landscape. R&D is being cut and the trend is to find drugs that are promising and partner or buyout...
Most don't even look at anything under $100M......

As we now know, PHII looks good and warrants a PHIII....The partner will be the one designing the PHIII, so I would assume a deal will have to be done by years end, at least announced by then...Would not expect it until NOV-DEC.